risedronate: Clinical Trials

7 trials of risedronate, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed. 7 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 27Completed 7
Phase 11Completed 1
Phase 31Completed 1

Follow risedronate: new trials by email Literature Review of risedronate trials Research Report on risedronate

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Prophylactic Risedronate for Patients With Peripheral Lung Tumors Treated With SBRT
risedronate, Matching placebo - Lung Neoplasm
Phase 2CompletedWake Forest University Health Sciences842019-07-122026-08-03
Effect of Risedronate on Bone Morbidity in Fibrous Dysplasia of Bone
risedronate, placebo - Fibrous Dysplasia of Bone
Phase 2 / Phase 3CompletedInstitut National de la Santé Et de la Recherche Médicale, France802007-07-222021-08-30
Bisphosphonate Action on the Appendicular Skeleton: Evidence for Differential Effects
Ibandronate, Risedronate, Alendronate - Post-menopausal Osteoporosis
Phase 2CompletedSheffield Teaching Hospitals NHS Foundation Trust4102007-04-012018-03-06
Assess the Safety, Efficacy, and Pharmacokinetics of Immediate and Delayed Release Weekly Risedronate
risedronate - Postmenopausal Women
Phase 2CompletedWarner Chilcott1812006-07-012012-01-13
Safety, Pharmacokinetics, and Efficacy of 100, 150, and 200 mg Risedronate Administered to Women With Low BMD
risedronate, experimental - Postmenopausal
Phase 2CompletedWarner Chilcott3702004-04-012013-04-17
Risedronate in Postmenopausal Women With Low Bone Density
RISEDRONATE - OSTEOPOROSIS, POSTMENOPAUSAL
Phase 2CompletedSanofi1502002-11-012012-02-17
Randomized Trial of Risedronate to Prevent Bone Loss in Renal Transplant Recipients.
Risedronate, Placebo - Renal Transplant Osteodystrophy
Phase 1 / Phase 2CompletedMontefiore Medical Center602002-10-012019-03-01

Conditions studied

Osteoporosis, Postmenopausal (2)  ·  Fibrous Dysplasia of Bone (1)  ·  Lung Neoplasms (1)  ·  Osteoporosis (1)

Sponsors

Warner Chilcott (2)  ·  Institut National de la Santé Et de la Recherche Médicale, France (1)  ·  Montefiore Medical Center (1)  ·  Sanofi (1)  ·  Sheffield Teaching Hospitals NHS Foundation Trust (1)  ·  Wake Forest University Health Sciences (1)

Countries

United States (4)  ·  Netherlands (2)  ·  Belgium (1)  ·  Canada (1)  ·  Croatia (1)  ·  France (1)  ·  Germany (1)  ·  Poland (1)  ·  United Kingdom (1)

Top investigators

Angela Rogers, Dr (1)  ·  Eugene McCloskey, Dr (1)  ·  John Beary, MD (1)  ·  Lu A Sun, MD, PhD (1)  ·  Margaret Paggiosi, Dr (1)  ·  Maria Coco, MD, MS (1)  ·  Michael Farris, MD (1)  ·  Rosemary Hannon, Dr (1)

Results publications

PMID 22797188

NIH funding

P30CA012197 (1)